Reglagene

Reglagene is a breakthrough therapy company dedicated to designing small-molecule treatments capable of crossing the blood-brain barrier. With current treatment methods offering only a one-year survival rate for cancer, Reglagene's new drug has the potential to revolutionize the treatment of high-grade gliomas, metastatic brain cancer, and neurological disorders. The company’s core expertise lies in the design and development of brain-penetrating drugs, enabling them to directly address these diseases.